Russ Berman News Today

Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How can you understand life if you don’t look at it live?  “It was such a simple statement, but it was kind of eye opening to […]

Eikon Therapeutics closes $148M financing to develop super-resolution microscopy 06 May 2021 California-based firm to integrate advanced optics, machine learning with biochemistry; its target application is drug discovery. Eikon focuses on live-cell super-resolution microscopy for drug discovery.Eikon Therapeutics, a Hayward, California-based company focused on live-cell super-resolution microscopy and engineering for drug discovery, has this week announced that it has closed a $148 million S...